Syapse Expands Oncology Real-World Data Offerings with Introduction of Syapse Cohorts: Essentials
May 22 2024 - 11:46AM
Syapse, a leading real-world oncology data company announced the
launch of its latest real-world data offering: Syapse Cohorts:
Essentials. This new offering expands upon Syapse’s existing
offering of Enriched Cohorts, and is designed to empower cancer
researchers and life sciences companies with unparalleled insights
via fit-for-purpose datasets to address key questions across all
cancer types.
Syapse Cohorts: Essentials is a
foundational solution that provides users with a robust dataset of
de-identified patient information. Syapse collects and normalizes
critical data elements from Health System partners, molecular labs,
mortality data and cancer registry data. This data is harmonized
and assembled into research-ready analytical datasets which include
demographic information, diagnosis details, early treatment
patterns, and outcomes. Users can access this data for over 50
different tumor types.
The existing Syapse Cohorts: Enriched
takes data depth and specificity to the next level. This advanced
tier includes all features from the Essentials Cohort plus
additional curation by Syapse Oncology Data Specialists to ensure
even greater depth and completeness across the patient journey.
Users benefit from enriched datasets with additional clinical
details such as genetic and molecular profiling, detailed treatment
regimens, and longitudinal patient outcomes, for an even wider
array of use cases.
"We are excited to introduce Syapse
Cohorts: Essentials to the cancer research community,” said Thomas
Brown, MD, MBA, Chief Medical Officer of Syapse. “This new offering
allows our customers to easily leverage our real-world data across
more than 50 tumor types from the Syapse Learning Health Network.
By offering both foundational datasets in Syapse Cohorts:
Essentials and highly curated datasets in Syapse Cohorts: Enriched,
we enable researchers to access precisely the information they
need, facilitating more personalized and impactful cancer research
and treatments.”
With these new tiers, Syapse continues
to demonstrate its commitment to leveraging real-world data to
enhance cancer research and treatment. The launch of Syapse
Cohorts: Essentials, as a complement to Syapse Cohorts: Enriched,
expands the company’s impact in supporting the oncology ecosystem
with high-quality, comprehensive data solutions.
About Syapse:
Syapse is a market leader in
real-world data solutions for oncology. The company's platform
enables healthcare providers, researchers, and life sciences
companies to harness the power of real-world data to improve
outcomes for patients with cancer. Through its innovative
solutions, Syapse is committed to advancing precision medicine and
transforming cancer care.
For more information about Syapse
Cohorts: Essentials and Syapse Cohorts: Enriched, please visit
www.syapse.com or contact marketing@syapse.com.
Contact:
Devon HellmanMarketing
Managerdevon.hellman@syapse.com